Literature DB >> 3567064

A cytotoxic DNA precursor is taken up selectively by human cancer xenografts.

K D Bagshawe, J Boden, G M Boxer, D W Britton, A Green, T Partridge, B Pedley, S Sharma, P Southall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3567064      PMCID： PMC2001750          DOI： 10.1038/bjc.1987.58

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  14 in total

Review 1.  A REVIEW OF SOME ASPECTS OF 5-IODODEOXYURIDINE AND AZAURIDINE.

Authors:  W H PRUSOFF
Journal:  Cancer Res       Date:  1963-09       Impact factor: 12.701

2.  Changes in the deoxyribonucleoside triphosphate pools of mouse 5178Y lymphoma cells following exposure to methotrexate or 5-fluorouracil.

Authors:  M H Tattersall; K R Harrap
Journal:  Cancer Res       Date:  1973-12       Impact factor: 12.701

3.  Incorporation of 131 iododeoxyuridine into the DNA of tumour-bearing rats after partial synchronization as a tool in scintigraphic tumour localization.

Authors:  J Schuhmacher; H Kampmann; J Mattern; M Volm; K Wayss; J Zimmerer
Journal:  Nucl Med (Stuttg)       Date:  1974-01-15

4.  Alternative de novo and "salvage" pathways to thymidine triphosphate synthesis: possible implications for cancer chemotherapy.

Authors:  T W Sneider; V R Potter
Journal:  Cancer Res       Date:  1969-12       Impact factor: 12.701

5.  Therapeutic effects of hydroxyurea. Experience with 118 patients with inoperable solid tumors.

Authors:  I M Ariel
Journal:  Cancer       Date:  1970-03       Impact factor: 6.860

6.  Overproduction of the free radical of ribonucleotide reductase in hydroxyurea-resistant mouse fibroblast 3T6 cells.

Authors:  L Akerblom; A Ehrenberg; A Gräslund; H Lankinen; P Reichard; L Thelander
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

7.  Genetic instability in the development of drug resistance.

Authors:  J H Goldie; A J Coldman
Journal:  Semin Oncol       Date:  1985-09       Impact factor: 4.929

8.  Different activities of unscheduled DNA synthesis in human melanoma and bone marrow cells.

Authors:  R Lewensohn; U Ringborg; J Hansson
Journal:  Cancer Res       Date:  1982-01       Impact factor: 12.701

9.  Modulation of 5-iodo-2'-deoxyuridine metabolism and cytotoxicity in human bladder cancer cells by fluoropyrimidines.

Authors:  A B Benson; D L Trump; K B Cummings; P H Fischer
Journal:  Biochem Pharmacol       Date:  1985-11-01       Impact factor: 5.858

10.  Reversed-role chemotherapy for resistant cancer.

Authors:  K D Bagshawe
Journal:  Lancet       Date:  1986-10-04       Impact factor: 79.321
View more
  3 in total

1.  Radiolabeled cyclosaligenyl monophosphates of 5-iodo-2'-deoxyuridine, 5-iodo-3'-fluoro-2',3'-dideoxyuridine, and 3'-fluorothymidine for molecular radiotherapy of cancer: synthesis and biological evaluation.

Authors:  Zbigniew P Kortylewicz; Yu Kimura; Kotaro Inoue; Elizabeth Mack; Janina Baranowska-Kortylewicz
Journal:  J Med Chem       Date:  2012-03-08       Impact factor: 7.446

2.  In vivo uptake of 131I-5-iodo-2-deoxyuridine by malignant tumours in man.

Authors:  P A Philip; K D Bagshawe; F Searle; A J Green; R H Begent; E S Newlands; G J Rustin; T Adam
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

3.  The influence of high dose hydroxyurea on the incorporation of 5-iodo-2-deoxyuridine (IUdR) by human bone marrow and tumour cells in vivo.

Authors:  P A Philip; L Kaklamanis; J Carmichael; K Tonkin; H Morrison; K Gatter; A L Harris
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.